Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin 1, 3, and 6 mg in insomnia patients. DESIGN: Adults (18-64 y) with chronic primary insomnia (DSM-IV) were randomly assigned to one of four sequences of 1 mg, 3 mg, and 6 mg of doxepin, and placebo in a crossover study. Treatment period...

Full description

Saved in:
Bibliographic Details
Main Authors: Roth, Thomas, Rogowski, Roberta, Hull, Steven, Schwartz, Howard, Koshorek, Gail, Corser, Bruce, Seiden, David, Lankford, Alan
Format: Artigo
Language:Inglês
Published: Associated Professional Sleep Societies, LLC 2007
Subjects:
Insomnia
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2082089/
https://ncbi.nlm.nih.gov/pubmed/18041488
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items